EUVIMEDEUVIMED entdecken
Crossref

A clinical study on topical insulin in fungal keratitis with corneal epithelial defects

Purva Gadoeya

Bioinformation · 31.10.2026 · 22 (10) · 7174-7177

DOI: 10.6026/973206300227174 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioinformation, online erschienen am 31.10.2026. Verfasst von Purva Gadoeya.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fungal keratitis remains an important cause of corneal morbidity, particularly in tropical regions. Therefore, it is of interest to evaluate the efficacy of topical insulin in fungal keratitis with corneal epithelial defects. Hence, eighty patients with fungal keratitis and corneal epithelial defects were included. Patients received either topical insulin 1 IU/mL four times daily in addition to conventional treatment or conventional treatment alone. Mean defect breadth decreased from 4.36 +/- 2.37 to 1.97 +/- 1.86 mm with insulin and from 4.31 +/- 1.99 to 2.84 +/- 1.37 mm with conventional treatment; the corresponding reductions were 2.39 +/- 2.02 and 1.47 +/- 1.14 mm, respectively. Topical insulin is a useful, inexpensive adjunct for promoting epithelial healing, while appropriate antifungal therapy remains essential.

Zitieren

APA

Gadoeya, P. (2026). A clinical study on topical insulin in fungal keratitis with corneal epithelial defects. Bioinformation, 22(10), 7174-7177. https://doi.org/10.6026/973206300227174

Vancouver

Gadoeya P. A clinical study on topical insulin in fungal keratitis with corneal epithelial defects. Bioinformation. 2026;22(10):7174-7177. doi:10.6026/973206300227174

BibTeX
@article{Gadoeya2026,
  author = {Gadoeya, Purva},
  title = {A clinical study on topical insulin in fungal keratitis with corneal epithelial defects},
  journal = {Bioinformation},
  year = {2026},
  volume = {22},
  number = {10},
  pages = {7174--7177},
  doi = {10.6026/973206300227174}
}
Kostenlos starten →